Search

Search Constraints

You searched for: Author/Creator Muhith, Abdul

Search Results

4. Safety monitoring of two and four-weekly adjuvant durvalumab for patients with stage III NSCLC: implications for the COVID-19 pandemic and beyond. (June 2021)